Beam Therapeutics Inc’s recent filing unveils that its President Ciaramella Giuseppe unloaded Company’s shares for reported $1.35 million on Nov 06 ’24. In the deal valued at $26.36 per share,51,110 shares were sold. As a result of this transaction, Ciaramella Giuseppe now holds 109,150 shares worth roughly $2.91 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ciaramella Giuseppe sold 51,110 shares, generating $1,342,752 in total proceeds. Upon selling the shares at $26.27, the President now owns 160,260 shares.
Before that, Giuseppe Ciaramella bought 102,220 shares. Beam Therapeutics Inc shares valued at $2,519,723 were divested by the Officer at a price of $24.65 per share.
Leerink Partners upgraded its Beam Therapeutics Inc [BEAM] rating to an Outperform from a a Market perform in a research note published on November 06, 2024; the price target was increased to $39 from $27. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. H.C. Wainwright began covering BEAM with “Buy” recommendation on July 23, 2024. JP Morgan revised its rating on January 29, 2024. It rated BEAM as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of BEAM
On Monday, Beam Therapeutics Inc [NASDAQ:BEAM] saw its stock jump 6.39% to $26.65. Over the last five days, the stock has gained 10.49%. Beam Therapeutics Inc shares have fallen nearly -2.09% since the year began. Nevertheless, the stocks have fallen -10.18% over the past one year. While a 52-week high of $49.50 was reached on 02/27/24, a 52-week low of $20.84 was recorded on 04/25/24. SMA at 50 days reached $24.54, while 200 days put it at $26.74.
Levels Of Support And Resistance For BEAM Stock
The 24-hour chart illustrates a support level at 25.86, which if violated will result in even more drops to 25.07. On the upside, there is a resistance level at 27.17. A further resistance level may holdings at 27.69. The Relative Strength Index (RSI) on the 14-day chart is 55.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.91%. Stochastics %K at 30.27% indicates the stock is a holding.
How much short interest is there in Beam Therapeutics Inc?
A steep rise in short interest was recorded in Beam Therapeutics Inc stocks on 2024-10-31, growing by 0.96 million shares to a total of 12.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 11.36 million shares. There was a rise of 7.78%, which implies that there is a positive sentiment for the stock.
